SNMMI monitors possible Mo-99 shortfall amid pandemic | Phone-based CBT may benefit Parkinson's patients with depression | Study: Interventions can curb pediatric cancer deaths
April 3, 2020
CONNECT WITH SNMMI LinkedInFacebookTwitterYoutube
SNMMI SmartBrief
News for nuclear medicine and molecular imaging professionalsSIGN UP ⋅   SHARE
Top Story
SNMMI is tracking a likely molybdenum-99 shortage after Nuclear Medicine Europe announced that a bulk shipment of the radioisotope from South Africa was interrupted because of flight restrictions caused by the coronavirus pandemic. However, other reactors manufacturing Mo-99 are continuing operation and production with enhanced staff protections, according to the NME
Full Story: Radiology Business (4/2) 
LinkedIn Twitter Facebook Email
Clinical News & Research
Forty percent of people with Parkinson's disease and depression who underwent telephone-based cognitive behavioral therapy had significantly improved anxiety, depression and quality of life, compared with unchanged mental health status among all of those who were given standard treatment, according to a study in Neurology. The findings suggest that CBT has lasting benefits and may be used in tandem with neurological care to improve Parkinson's outcomes, lead researcher Roseanne Dobkin said.
Full Story: Futurity (4/2) 
LinkedIn Twitter Facebook Email
Researchers estimated that there will be 13.7 million new cases of pediatric cancer worldwide between 2020 and 2050, as well as 11.1 million pediatric cancer deaths, including 84.1% in low-income and lower-middle-income nations, if no supplementary investments are made to enhance childhood cancer treatment or improve access to health care services. The findings, published in The Lancet Oncology, also showed that 56.1% of the projected number of deaths could be prevented with concurrent and comprehensive scale-up of interventions during the same period.
Full Story: Physician's Briefing/HealthDay News (4/1) 
LinkedIn Twitter Facebook Email
Researchers evaluated over 980,500 Norwegian children born at term and found that babies who were exposed to preeclampsia during pregnancy had higher odds of developing intellectual disability, epilepsy, autism spectrum disorder and attention-deficit/hyperactivity disorder, as well as a slightly higher risk of developing hearing or vision loss, compared with those whose mothers had no preeclampsia. The findings, published in JAMA Psychiatry, also showed that those who were exposed to preeclampsia had a lower mean gestational age at 39.3 weeks and had a lower average birthweight of 3,463 grams, compared with 39.8 weeks and 3,628 grams among babies with no exposure.
Full Story: MedPage Today (free registration) (4/1) 
LinkedIn Twitter Facebook Email
Industry Report
The second closing of its Series B funding round brought in $125 million for immunotherapy startup iTeos Therapeutics. The new capital will be used to continue work on two cancer treatments it is developing.
Full Story: Xconomy (4/2) 
LinkedIn Twitter Facebook Email
News from the Field
Cancer treatments or injectable medicines given in a doctor's office are being affected by the coronavirus, and difficult decisions need to be made. Which treatments are essential, who to start on immunosuppressive drugs, and who to continue on such medications are all difficult questions patients and doctors face.
Full Story: BioPharma Dive (4/1) 
LinkedIn Twitter Facebook Email
Health Policy
Federal officials seized more than 920,000 items of personal protective equipment, including 598,000 medical-grade gloves and 192,000 N95 respirator masks, from an individual hoarder and have distributed the confiscated PPE to health care providers in New Jersey and New York. SNMMI and other imaging organizations have called on President Donald Trump to assist radiologists with severe PPE shortages.
Full Story: CNN (4/3),  Radiology Business (4/2) 
LinkedIn Twitter Facebook Email
President Donald Trump suggested he may reconsider the administration's decision not to reopen Affordable Care Act marketplace exchange enrollment to help the uninsured affected by the novel coronavirus pandemic. Trump said at a briefing Wednesday that he is considering using programs such as Medicare and Medicaid to help the uninsured but did not offer details.
Full Story: Politico (4/1),  Modern Healthcare (tiered subscription model) (4/1) 
LinkedIn Twitter Facebook Email
Advancing Health Care
New York City, New Orleans and Seattle are the nation's COVID-19 hot spots, but state-level maps obscure the disease's spread in other regions of the US. A new map showing confirmed COVID-19 infections per county, adjusted for population size, shows significant clusters and suggests areas with comparatively fewer resources could be more greatly affected.
Full Story: Scientific American online (4/2) 
LinkedIn Twitter Facebook Email
Save 10% on Practical Mathematics in Nuclear Medicine Technology, 2nd edition, and the 5th edition of the Review of Nuclear Medicine Technology when you purchase them together as part of this best-selling package. It's an in-depth review at a great price! Order now.
LinkedIn Twitter Facebook Email
Deadlines are approaching for the Ursula Mary-Kocemba Slosky, PhD, Professional Relations Fellowship ($1K+travel, April 7); and technologist career advancement grants (13 at $500, May 4). Find out more.
LinkedIn Twitter Facebook Email
SNMMI | Join/Renew Your Membership | MySNMMI | Meetings
Education | News & Publications | Advocacy | Donate
Start by doing what's necessary; then do what's possible; and suddenly you are doing the impossible.
Francis of Assisi,
patron saint of Italy, animals, ecology
LinkedIn Twitter Facebook Email
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items above are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004